Figure 2.
Percent of UK Biobank participants with new blood pressure (BP) medicine use at 5‐year follow‐up according to shift work status stratified by circadian preference (N=9200).
Percent of UK Biobank participants with new blood pressure (BP) medicine use at 5‐year follow‐up according to shift work status stratified by circadian preference (N=9200).